← Russell 3000 cross-section

AHCO AdaptHealth Corp.

Trailing twelve months to 2026-06-30 · as filed 2026-08-04, not restated
Healthcare

Scale

Market cap
$746m
Revenue TTM
$3.2bn
Net income TTM
$-228m
Free cash flow
$98m
Composite score
49.1
Sector rank
#2195

Valuation

P / E
EV / EBITDA
9.4
EV / sales
0.8
FCF yield
13.09%
Earnings yield vs 10-yr
-35.30pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-7.1%
EBITDA margin
8.6%
ROE
-16.6%
ROIC
-4.4%
Revenue growth
-0.4%

Insider activity, last 90 days

Net open-market
$0.16m
Buyers
2
Sellers
1

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

AdaptHealth has experienced inflationary pressure and higher costs as a result of increased cost of materials, labor, shipping and transportation. Cost of net revenue primarily includes the cost of non-capitalized medical equipment and supplies, distribution expenses, labor costs, facilities and vehicle rental costs, and depreciation for capitalized patient equipment. The comparability of AdaptHealth's net revenue between periods was impacted by certain factors as described below. (a) All changes in reported net revenue from the comparable period presented excluding the impacts from acquisition (b) and disposition (c). …AdaptHealth Corp., 10-Q, period ended 2026-06-30, filed 2026-08-04

Read the full passage →